Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

5 Can't-Miss Health-Care Events This Week
Motley Fool
Sunday, February 24, 2013 - 2:29pm
tags:
Onyx, Bayer, Zogenix, Ariad, Questcor, Medivation
A Global Leader in Animal Health - Spinoff Opportunity?
Motley Fool
Sunday, February 24, 2013 - 2:27pm
tags:
Zoetis
Johnson & Johnson's Pioneering Zytiga And Its Competitors
Seeking Alpha
Sunday, February 24, 2013 - 2:24pm
tags:
Zytiga. ARN-509, Xtandi, prostate cancer, Medivation, JNJ, Astellas, Aragon, Tokai
Is AbbVie Wasting Your Money?
Motley Fool
Sunday, February 24, 2013 - 2:23pm
tags:
AbbVie
J&J Hip Designer Says He Gave Complaints to Marketers
Bloomberg
Sunday, February 24, 2013 - 2:22pm
tags:
JNJ, hip replacements, devices, recalls, hip recall
Affymax, Takeda recall anaemia drug Omontys after deaths
Reuters
Sunday, February 24, 2013 - 2:20pm
tags:
Takeda, recalls, Omontys, Affymax
This Week in Biotech
Motley Fool
Sunday, February 24, 2013 - 2:20pm
tags:
Roche, Immunogen, Repros Therapeutics, Chelsea Therapeutics, Gilead Sciences, Vivus
BGI-Shenzhen Extends Tender Offer For Complete Genomics, inc.
Yahoo/PR Newswire
Sunday, February 24, 2013 - 2:18pm
tags:
BGI-Shenzhen, Complete Genomics, M&A
Vivus, Inc.: Second Rejection And Upcoming Earnings, Patience Required For Investors
Seeking Alpha
Friday, February 22, 2013 - 11:37am
tags:
Vivus, earnings, Qsymia
EMA recommends extended indications for Glaxo's Cervarix
Yahoo/Fly on the Wall
Friday, February 22, 2013 - 11:12am
tags:
GSK, Cervarix, Europe, HPV
InterMune Earnings: Here’s Why Shares are Up Now
Wall St. Cheat Sheet
Friday, February 22, 2013 - 11:10am
tags:
earnings, InterMune
Exelixis Earnings: Everything You Must Know Now
Wall St. Cheat Sheet
Friday, February 22, 2013 - 11:09am
tags:
earnings, Exelixis
Pluristem Gets FDA's Orphan Drug Nod for Anemia Treatment
Motley Fool
Friday, February 22, 2013 - 11:08am
tags:
orphan drugs, Pluristem, FDA, placental expanded cells
FDA OKs Roche drug for late-stage metastatic breast cancer
Reuters
Friday, February 22, 2013 - 11:01am
tags:
Roche, metastatic breast cancer, breast cancer, Kadcyla
Labeling Considerations in the European Union and its Impact on Global Labeling Compliance
CP Wire
Friday, February 22, 2013 - 10:54am
tags:
Europe, labeling, compliance
Bausch & Lomb Owner Said to Seek Banks for IPO as Sale Falters
Bloomberg
Friday, February 22, 2013 - 10:49am
tags:
Bausch & Lomb, IPO, M&A
UCB - ConfometRx Collaborate
Yahoo/Zacks
Friday, February 22, 2013 - 10:48am
tags:
UCB, ConfometRx, G protein coupled receptors
In U.S., flu vaccine worked in just over half of those who got it
Reuters
Friday, February 22, 2013 - 10:46am
tags:
vaccines, Flu, flu vaccines
CHMP rejects Vivus diet pill again
Pharma Times, UK
Friday, February 22, 2013 - 10:45am
tags:
Vivus, Europe, Qsiva, Qsymia
Elan to return $1 billion to shareholders from multiple sclerosis drug sale
Reuters
Friday, February 22, 2013 - 10:44am
tags:
Elan, Tysabri, share repurchase

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.